Veracyte Inc’s recent filing unveils that its Director JONES EVAN/ FA unloaded Company’s shares for reported $0.24 million on Mar 01 ’24. In the deal valued at $24.36 per share,10,000 shares were sold. As a result of this transaction, JONES EVAN/ FA now holds 37,601 shares worth roughly $0.8 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, JONES EVAN/ FA sold 3,090 shares, generating $93,232 in total proceeds. Upon selling the shares at $30.17, the Director now owns 35,173 shares.
Before that, JONES EVAN/ FA sold 838 shares. Veracyte Inc shares valued at $25,257 were divested by the Director at a price of $30.14 per share. As a result of the transaction, JONES EVAN/ FA now holds 37,601 shares, worth roughly $0.8 million.
Needham reiterated its Veracyte Inc [VCYT] rating to a Buy in a research note published on February 23, 2024; the price target was $33. A number of analysts have revised their coverage, including Raymond James’s analysts, who decreased its forecast for the stock in mid January from “an Outperform” to “a Mkt perform”. Scotiabank began covering VCYT with “Sector outperform” recommendation on January 05, 2023. Stephens started covering the stock on January 07, 2022. It rated VCYT as “an Overweight”.
Price Performance Review of VCYT
On Tuesday, Veracyte Inc [NASDAQ:VCYT] saw its stock jump 0.76% to $21.16. Over the last five days, the stock has lost -2.35%. Veracyte Inc shares have fallen nearly -23.08% since the year began. Nevertheless, the stocks have fallen -3.69% over the past one year. While a 52-week high of $30.52 was reached on 01/08/24, a 52-week low of $19.52 was recorded on 03/26/24. SMA at 50 days reached $24.03, while 200 days put it at $24.88. A total of 0.61 million shares were traded, compared to the trading of 0.47 million shares in the previous session.
Levels Of Support And Resistance For VCYT Stock
The 24-hour chart illustrates a support level at 20.70, which if violated will result in even more drops to 20.24. On the upside, there is a resistance level at 21.56. A further resistance level may holdings at 21.95. The Relative Strength Index (RSI) on the 14-day chart is 35.73, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.67, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 83.72%. Stochastics %K at 8.69% indicates the stock is a buying.
How much short interest is there in Veracyte Inc?
A steep rise in short interest was recorded in Veracyte Inc stocks on Feb 29, 2024, growing by 0.26 million shares to a total of 2.72 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 2.46 million shares. There was a rise of 9.56%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 4.10% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.23.
